16th Mar 2021 14:14
FORM 8.3
Amendment to Purchase
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | AON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 12 March 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) | Relevant securities |
|
|
|
|
466,204 | 0.21% | 1,792,884 | 0.79% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
106,445 | 0.05% | 30,257 | 0.01% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
purchase/sell: | 24,200 | 0.01% | 24,200 | 0.01% | |
|
|
|
| ||
(4) | TOTAL: |
|
|
|
|
596,849 | 0.26% | 1,847,341 | 0.82% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 3 | 228.1600 USD |
Purchase | 7 | 227.9700 USD |
Purchase | 8 | 227.9837 USD |
Purchase | 8 | 228.1437 USD |
Purchase | 10 | 228.0495 USD |
Purchase | 14 | 228.0550 USD |
Purchase | 19 | 228.0610 USD |
Purchase | 38 | 228.9257 USD |
Purchase | 72 | 228.0533 USD |
Purchase | 106 | 228.0019 USD |
Purchase | 185 | 229.3754 USD |
Purchase | 200 | 227.8951 USD |
Purchase | 200 | 228.2500 USD |
Purchase | 258 | 228.0800 USD |
Purchase | 300 | 227.9866 USD |
Purchase | 386 | 228.2818 USD |
Purchase | 504 | 228.1357 USD |
Purchase | 505 | 228.0420 USD |
Purchase | 600 | 228.0636 USD |
Purchase | 673 | 228.1030 USD |
Purchase | 725 | 228.0342 USD |
Purchase | 794 | 228.0434 USD |
Purchase | 802 | 228.2584 USD |
Purchase | 900 | 228.1616 USD |
Purchase | 939 | 228.1759 USD |
Purchase | 1,200 | 229.0000 USD |
Purchase | 1,219 | 228.0772 USD |
Purchase | 1,252 | 228.0775 USD |
Purchase | 1,271 | 228.0532 USD |
Purchase | 1,325 | 228.0845 USD |
Purchase | 1,793 | 228.0179 USD |
Purchase | 2,260 | 228.0582 USD |
Purchase | 3,801 | 228.0081 USD |
Purchase | 6,142 | 228.1302 USD |
Purchase | 11,359 | 228.3795 USD |
Purchase | 11,458 | 228.3577 USD |
Purchase | 15,043 | 228.0000 USD |
Purchase | 15,737 | 228.0480 USD |
Purchase | 25,197 | 228.1849 USD |
Sale | 2 | 228.1400 USD |
Sale | 3 | 228.0233 USD |
Sale | 4 | 228.1000 USD |
Sale | 7 | 229.4500 USD |
Sale | 12 | 229.5500 USD |
Sale | 100 | 227.8300 USD |
Sale | 100 | 228.2000 USD |
Sale | 142 | 227.5361 USD |
Sale | 166 | 229.3596 USD |
Sale | 172 | 228.3569 USD |
Sale | 300 | 227.9866 USD |
Sale | 600 | 228.3283 USD |
Sale | 1,203 | 228.9975 USD |
Sale | 1,259 | 228.0125 USD |
Sale | 1,715 | 228.3521 USD |
Sale | 2,131 | 228.1089 USD |
Sale | 2,241 | 228.0570 USD |
Sale | 2,634 | 228.1792 USD |
Sale | 3,897 | 228.0178 USD |
Sale | 8,735 | 228.0606 USD |
Sale | 9,346 | 228.4139 USD |
Sale | 10,233 | 228.3755 USD |
Sale | 11,449 | 228.0256 USD |
Sale | 15,934 | 228.0000 USD |
Sale | 35,717 | 228.1656 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 16 Mar 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
to which the option | |||||
or derivative | |||||
relates | |||||
Put Options | Purchased | -1,200 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 1,200 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 23,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -23,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005730/en/
Copyright Business Wire 2021
Related Shares:
Aon Cl A OrdBarclays